A detailed history of Inspire Investing, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Inspire Investing, LLC holds 7,888 shares of CYTK stock, worth $376,888. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,888
Previous 6,571 20.04%
Holding current value
$376,888
Previous $356,000 16.85%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$51.22 - $60.16 $67,456 - $79,230
1,317 Added 20.04%
7,888 $416,000
Q2 2024

Aug 12, 2024

BUY
$47.86 - $75.05 $71,024 - $111,374
1,484 Added 29.17%
6,571 $356,000
Q1 2024

May 07, 2024

BUY
$63.75 - $108.06 $38,568 - $65,376
605 Added 13.5%
5,087 $356,000
Q4 2023

Feb 12, 2024

SELL
$26.88 - $83.49 $158,108 - $491,088
-5,882 Reduced 56.75%
4,482 $374,000
Q3 2023

Oct 26, 2023

BUY
$29.46 - $36.61 $22,183 - $27,567
753 Added 7.83%
10,364 $305,000
Q2 2023

Jul 31, 2023

BUY
$32.62 - $40.75 $62,858 - $78,525
1,927 Added 25.08%
9,611 $313,000
Q1 2023

Apr 24, 2023

BUY
$33.36 - $45.71 $84,100 - $115,234
2,521 Added 48.83%
7,684 $270,000
Q4 2022

Jan 26, 2023

BUY
$35.77 - $51.11 $29,617 - $42,319
828 Added 19.1%
5,163 $0
Q3 2022

Nov 07, 2022

SELL
$38.54 - $54.52 $39,580 - $55,992
-1,027 Reduced 19.15%
4,335 $210,000
Q2 2022

Aug 10, 2022

SELL
$33.93 - $48.92 $892,257 - $1.29 Million
-26,297 Reduced 83.06%
5,362 $211,000
Q1 2022

Apr 21, 2022

BUY
$29.74 - $46.0 $778,950 - $1.2 Million
26,192 Added 479.09%
31,659 $1.17 Million
Q4 2021

Feb 14, 2022

BUY
$34.35 - $46.38 $187,791 - $253,559
5,467 New
5,467 $249,000
Q4 2021

Feb 03, 2022

SELL
$34.35 - $46.38 $242,579 - $327,535
-7,062 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$18.54 - $35.74 $130,929 - $252,395
7,062 New
7,062 $252,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.5B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.